TLDR Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.
The study discussed disorders in male children linked to insufficient androgen action, focusing on the roles of testosterone and dihydrotestosterone (DHT) in virilization. It highlighted that mutations in the 5α-reductase type 2 (5αR-2) gene or androgen receptor (AR) gene, as well as environmental endocrine disruptors, could impair androgen action, leading to conditions like hypospadias, cryptorchidism, and micropenis. The research emphasized the need to consider environmental chemicals as potential disruptors of normal male sexual differentiation, alongside natural genetic mutations.
78 citations
,
August 1996 in “The Journal of Clinical Endocrinology & Metabolism” The same gene mutation can cause different symptoms in family members.
237 citations
,
December 2001 in “Urology” Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.
January 2025 in “Case Reports in Genetics” A rare gene variant causes sexual development issues in siblings, needing personalized treatment.
32 citations
,
April 1999 in “Expert Opinion on Investigational Drugs” Finasteride effectively treats male hair loss, improving growth and density.
50 citations
,
February 2013 in “Annals of Clinical Biochemistry” Understanding how DHT works is important for diagnosing and treating hormone-related disorders.
5 citations
,
January 2001 in “Advances in protein chemistry” 5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.
11 citations
,
August 2020 in “Diabetes” Testosterone helps human pancreatic cells increase insulin release.